A phase I randomized study to evaluate safety, pharmacokinetics, and pharmacodynamics of SIR2446M, a selective RIPK1 inhibitor, in healthy participants

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Ana Liza Andresan Sun, John David Gillies, Yang Shen, Huajun Deng, Fenchao Xue, Yongfen Ma, Linan Song
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Clinical and Translational Science
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet